QUERZOLI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 10.301
AS - Asia 5.401
EU - Europa 3.947
SA - Sud America 887
AF - Africa 135
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.694
Nazione #
US - Stati Uniti d'America 10.032
SG - Singapore 2.070
CN - Cina 1.431
IT - Italia 1.208
BR - Brasile 696
DE - Germania 620
VN - Vietnam 567
UA - Ucraina 472
GB - Regno Unito 366
HK - Hong Kong 352
TR - Turchia 316
FI - Finlandia 249
PL - Polonia 216
SE - Svezia 192
FR - Francia 184
CA - Canada 147
RU - Federazione Russa 136
BD - Bangladesh 129
IN - India 125
JP - Giappone 120
MX - Messico 99
ID - Indonesia 77
NL - Olanda 65
BE - Belgio 61
AR - Argentina 56
ZA - Sudafrica 55
ES - Italia 37
EC - Ecuador 36
IQ - Iraq 33
PK - Pakistan 29
CO - Colombia 28
AT - Austria 26
CZ - Repubblica Ceca 24
MA - Marocco 23
VE - Venezuela 23
LT - Lituania 22
UZ - Uzbekistan 20
PH - Filippine 16
AU - Australia 15
MY - Malesia 15
CL - Cile 14
PY - Paraguay 12
RO - Romania 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
KE - Kenya 11
SA - Arabia Saudita 11
TN - Tunisia 9
UY - Uruguay 9
CH - Svizzera 8
AZ - Azerbaigian 7
BO - Bolivia 7
IR - Iran 7
JO - Giordania 7
KR - Corea 7
KZ - Kazakistan 7
NP - Nepal 7
CR - Costa Rica 6
JM - Giamaica 6
AL - Albania 5
AO - Angola 5
DZ - Algeria 5
IE - Irlanda 5
OM - Oman 5
EU - Europa 4
GR - Grecia 4
HU - Ungheria 4
IL - Israele 4
MD - Moldavia 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
BG - Bulgaria 3
BH - Bahrain 3
DK - Danimarca 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
HR - Croazia 3
LY - Libia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
DO - Repubblica Dominicana 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
GA - Gabon 1
GD - Grenada 1
Totale 20.670
Città #
Singapore 1.294
Ashburn 1.147
Woodbridge 795
San Jose 763
Chandler 612
Fairfield 593
Ann Arbor 548
Jacksonville 503
Santa Clara 455
Beijing 425
Houston 398
Hong Kong 348
New York 269
Wilmington 268
Seattle 253
Warsaw 207
Los Angeles 206
Izmir 198
Cambridge 193
Dallas 193
Ho Chi Minh City 174
Munich 171
Nanjing 160
Hanoi 138
Tokyo 116
Princeton 113
Milan 107
Buffalo 100
Shanghai 92
Lauterbourg 91
Ferrara 89
Helsinki 83
Boardman 78
Council Bluffs 75
Nanchang 72
Turku 72
São Paulo 71
Bremen 69
Mexico City 65
Orem 65
Brooklyn 63
Dearborn 61
Brussels 60
San Diego 60
Montreal 54
Jakarta 53
Rome 53
Tianjin 49
Chennai 46
Shenyang 45
Hebei 41
Denver 38
London 38
Toronto 38
Chicago 37
Changsha 36
Falls Church 36
Atlanta 35
Johannesburg 34
Stockholm 32
Hefei 31
Manchester 31
Frankfurt am Main 29
Haiphong 29
The Dalles 29
Bologna 28
Da Nang 28
Falkenstein 28
Poplar 26
Rio de Janeiro 25
Boston 24
Phoenix 24
San Mateo 24
Zhengzhou 24
Jiaxing 23
Jinan 23
Redwood City 23
San Francisco 22
Auburn Hills 21
Guangzhou 21
Moscow 21
Amsterdam 20
Charlotte 18
Tashkent 18
Belo Horizonte 17
Nuremberg 17
Vienna 17
Brasília 16
New Delhi 16
Norwalk 16
Philadelphia 15
Querétaro 15
Ankara 14
City of London 14
Guayaquil 14
Mountain View 14
Addison 13
Brno 13
Ottawa 13
Palermo 13
Totale 13.405
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 663
Integrazione del Nottingham Prognostic Index con i fenotipi biologici per una migliore definizione prognostica delle pazienti affette da carcinoma della mammella. 544
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 302
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 297
Phospholipase C-beta2 promotes mitosis and migration of human breast cancer-derived cells 273
Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases 265
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 258
Breast Cancer and Simian Virus 40 Infection 257
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 256
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 243
CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer 237
Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation 233
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 233
Valutazione dell'espressione di GATA3 con tecnica del tissue microarray (TMA) e significato prognostico nel carcinoma mammario infiltrante 227
CD8 + ve cell infiltration correlates with angiogenesis in non-small cell lung cancer (NSCLC) of patients with chronic obstructive pulmonary disease 225
Serologic investigation on undifferentiated nasopharyngeal carcinoma and Simian Virus 40 infection 224
Application of quantitative analysis to biologic profile evaluation in breast cancer 224
Valutazione biologica multiparametrica di 5284 carcinomi mammari infiltranti (1990-2005): il ruolo del patologo nelle scelte terapeutiche 223
miR-501 overexpression in renal carcinomas 223
Il protocollo Diagnostico-Terapeutico e Assistenziale per il carcinoma mammario della Regione Emilia-Romagna. I edizione 222
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts 217
Sentinel node study in early breast cancer 217
Espressione dell'oncoproteina virale antigene T-grande di SV40 in carcinomi mammari infiltranti valutata su Tissue micro arrays (TMAs) 216
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score 214
Prognostic and therapeutic impact of sentinel node micrometastasis in patients with invasive breast cancer 212
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 207
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 206
Core needle biopsy in invasive breast cancer prognostic/predictive power: concordance with surgical speciemen and impact of immunophenotypes 204
Factors responsible of scintigraphic false-negative sentinel lymph node detection in brest cancer 203
Commentary on human mammary neoplasia. The Estrogen Receptor-promotion hypothesis 201
Espressione dei MicroRNA nei carcinomi mammari 200
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer 199
Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancer 199
Tumour-infiltrating CD8+ cells expressing IL-10, but not CD8+, CD4+ and CD68+ cells, are associated with a better prognosis in patients with NSCLC 196
Clinical-diagnostic meaning of mammary uptake accidentally detected during 18F-FDG PET/CT (PET): comparison between radiological imaging and histopathology. 195
The 70 Gene Mammaprint signature: Ferrara's experience 194
Contribution of cell kinetics with Ki-67 to the biopathological and prognostic characterization of breast cancer 190
An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer 190
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC 189
Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-insitutional study in Italy 189
Quantitative immunoprofiles of breast cancer performed by image analysis 188
Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression 187
BRCA1 LOH and biological profile of breast cancer. Comparison between two age groups. 186
PLC-β2 is highly expressed in breast cancer and is associated with a poor outcome: A study on tissue microarrays 185
Expression of IL-10 by CD8+ T Cells Is a Favorable Prognostic Factor in Non-Small Cell Lung Cancer 185
Biological profile of breast carcinoma in situ investigated by immunohistochemical technique 184
Loss of methylation at chromosome 11p15.5 is common in human adult tumors 183
Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodies 182
Biology and prognosis of 1685 recently diagnosed HER2 positive breast carcinomas 181
A case of invasive solid papillary breast carcinoma resembling tall cell variant of papillary thyroid carcinoma 181
Prognostic and predictive factors related to metastatic breast cancer clinical history: an outcome study [Fattori prognostici e predittivi nella storia clinica del carcinoma metastatico della mammella: Uno studio di esito] 180
Axillary lymph node nanometastases are prognostic factors for metastatic relapse 180
An original approach in the diagnosis of early breast cancer: use of the same radipharmaceutical for both non palpable lesions and sentinel node localization 176
The 70 gene Mammaprint signature: a comparison with traditional clinico-pathological parameters. 175
Biological tissue characterisation in narrow beam x-ray scattering techniques 174
Increased neurokinin-2 receptor expression in alveolar macrophages of smokers with COPD 171
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 171
Role of the miR-501 in Renal Carcinomas 171
Oncogenic role of miR-483-3p at the IGF2/483 locus 170
Prevalence of post-stress myocardial stunning by gated-SPECT in diabetic patients: results of a prospective, multi-center trial 169
Indicatori e valori di riferimento nella valutazione della ploidia del carcinoma mammario 168
Comparison of cytology test in patients under surveillance after transurethral resection of superficial urothelial carcinoma 168
Immunocytochemical Demonstration of Estrogen Receptors by Monoclonal antibodies in Human breast cancer: Correlation with estrogen receptor assay by Dextran-coated Charcoal Method 167
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: Evidence from a retrospective study 166
Interleukin (IL)-10 expression in non-small cell lung cancer is associated with cigarette smoking 165
Expression of p21 ras gene products in breast cancer relates to histological types and to receptor nodal status 163
The 70 gene Mammaprint Signature: a comparison with traditional clinco-pathological tools. 162
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer 162
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues 162
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 159
Increased of A3 adenosine receptors by depleted expression of polycystic kidney disease-1 gene (PKD1) in human renal cell and tissues: implication for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells 158
Cytoplasmic Trop-1/Ep-CAM Overexpression is Associated with a Favorable Outcome in Node-positive Breast Cancer 157
Treatment of a relapsing facial pyoderma gangrenosum (malignant pyoderma) 157
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women 157
Tumor infiltrating lymphocytes in triple negative breast cancer and correlations with prognosis 154
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase 154
Biological staging of incipient, in situ and invasive breast carcinomas 153
Quality control for biomarker determination in oncology: The experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT) 153
Interobserver reproducibility of immunohistochemical HER-2/neu assessment in human breast cancer: An update from INQAT round III 153
p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features 152
Urovysion(TM) test: confronto tra citologia convenzionale e citologia molecolare nel follow-up di pazienti affetti da patologia neoplastica dell'urotelio 151
Observational DEMETRA STUDY: survival of metastatic breast carcinoma patients after treatment with Trastuzumab 148
Morphological parameters of flat epithelial atypia (FEA) in stereotactic vacuum-assisted needle core biopsies do not predict the presence of malignancy on subsequent surgical excision 142
Sentinel node and bone marrow micro metastases and nanometastases 142
Lymph node micrometastases do influence breast cancer outcome 140
Clinical and therapeutic importance of sentinel node biopsy of the internal mammary chain in patients with breast cancer: a single-center study with long-term follow-up. 135
Interobserver reproducibility of immunohistochemical HER-2/neu evaluation in human breast cancer: The real-world experience 131
Pattern of distant recurrence according to the molecular subtypes identified by immunohistochemistry in women with early breast cancer 128
MicroRNAs: toward the clinic for breast cancer patients 125
Assessment of Proliferative rate of breast cancer by Ki-67 Monoclonal Antibody 125
Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters 120
The 70-Gene Mammaprint Signature for risk stratification in breast cancer: a comparison with traditional pathological and clinical tools 119
MicroRNA gene expression deregulation in human breast cancer 116
Tumor infiltrating lymphocyte (TIL) and CD8+ cells in TNBC: new prognostic markers 113
Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT Study): Interim results 112
null 111
Macrophage expression of IL-10 is a prognostic factor in non-small cell lung cancer. 111
90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells 111
I Tissue micro arrays come strumento di ricerca e loro possibile utilizzo nella pratica clinica routinaria 109
null 107
Totale 18.932
Categoria #
all - tutte 83.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 629
Totale 84.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 0 0 0 0 0 0 0 78
2021/20221.285 50 118 70 87 95 52 66 87 52 104 101 403
2022/20231.372 98 113 55 184 263 213 63 126 142 7 67 41
2023/2024729 68 63 45 21 56 167 30 53 8 17 30 171
2024/20253.026 91 84 225 84 376 282 83 154 513 316 448 370
2025/20268.014 814 306 697 1.046 1.258 546 919 378 819 823 348 60
Totale 20.836